Key result
In HLA-DPB1*1701 transgenic mice, beryllium sensitization and challenge resulted in a significant maximum increased ear thickness of 19.6% over baseline (p < 0.05).
The HLA-DPB1*1701 transgene product is an important risk factor for induction of the beryllium-sensitive phenotype in mice, providing a useful model for chronic beryllium disease.
Answers are grounded in this paper and cite their sources.
Provides a murine model for HLA-DPB1*1701-mediated beryllium sensitivity; leaves open human translation and clinical relevance.
Chronic beryllium disease (CBD), an irreversible, debilitating granulomatous lung disease is caused by exposure to beryllium. This occupational hazard occurs in primary production and machining of Be-metal, BeO, beryllium - containing alloys, and other beryllium products. CBD begins as an MHC Class II-restricted, T(H)1 hypersensitivity, and the Human Leukocyte Antigen, HLA-DPB1E(69), is associated with risk of developing CBD. Because inbred strains of mice have not provided good models of CBD to date, three strains of HLA-DPB1 transgenic mice in an FVB/N background were developed; each contains a single allele of HLA-DPB1 that confers a different magnitude of risk for chronic beryllium disease: HLA-DPB1*0401 (OR approximately 0.2), HLA-DPB1*0201 (OR approximately 3), and HLA-DPB1*1701 (OR approximately 46). The mouse ear swelling test (MEST) was employed to determine if these different alleles would support a hypersensitivity response to beryllium. Mice were first sensitized on the back and subsequently challenged on the ear. In separate experiments, mice were placed into one of three groups (sensitization/challenge): C/C, C/Be, and Be/Be. In the HLA-DPB1*1701 mice, the strain with the highest risk transgene, the Be/Be group was the only group that displayed significant maximum increased ear thickness of 19.6% +/- 3.0% over the baseline measurement (p < 0.05). No significant changes were observed in the other transgenic strains for any treatment condition. In addition, inter-strain differences in response to beryllium in seven inbred strains were investigated through use of the MEST, these included: FVB/N, AKR, Balb/c, C3H/HeJ, C57/BL6, DBA/2, and SJL/J. The FVB/N strain was least responsive, while the SJL/J and C57/BL6 strains were the highest responders. Our results suggest that the HLA-DPB1*1701 transgene product is an important risk factor for induction of the beryllium-sensitive phenotype. This model should be a useful tool for investigating beryllium sensitization.
No takes yet. Share an insight, caveat, or question.
Tarantino-Hutchison et al. (2009) studied Chronic beryllium disease. Beryllium sensitization and challenge vs. Control sensitization and/or challenge was evaluated on Maximum increased ear thickness over baseline measurement (p=< 0.05). In HLA-DPB1*1701 transgenic mice, beryllium sensitization and challenge resulted in a significant maximum increased ear thickness of 19.6% over baseline (p < 0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: